News brief
On 2026-07-13, according to Xiniu Data, Matwings completed Series A+ financing, raising hundreds of millions of RMB. Investors were co-lead investor Shanghai Weilaiyongxianqiye Consulting Partnership (Limited Partnership), co-lead investor Guotou Innovation, participating investor Jujieweixian, participating investor Jiaxingrunputianwuguquan Investment Partnership (Limited Partnership), participating investor Jinjing Capital, participating investor Shanghai Hanze Venture Capital Partnership (Limited Partnership), participating investor Caixin Capital, participating investor Qiming Venture Capital, participating investor Yonghua Investment, participating investor Bencao Capital, participating investor Shanghai Kechuang Fund. The company is a provider of AI-driven full-stack protein research and development platforms.
Connected profiles
Explore
Sources · 0Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
No source links are available for this profile.
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
2026年7月13日，据烯牛数据报道，天鹜科技完成A+轮融资，金额数亿人民币。投资方为上海未来涌现企业咨询合伙企业（有限合伙）、国投创新领投，聚杰微纤、嘉兴润璞天鹜股权投资合伙企业（有限合伙）、金景资本、上海涵泽创业投资合伙企业（有限合伙）、财鑫资本、启明创投、涌铧投资、本草资本、上海科创基金跟投。该公司为AI驱动全栈式蛋白质研发平台提供商。